Cargando…
Repurposing medicinal compounds for blood cancer treatment
Drug development is being continuously scrutinised for its lack of productivity. Novel drug development is associated with high costs, high failure rates and lengthy development process. These downfalls combined with a huge demand in blood cancer for new therapeutic treatments have led many to consi...
Autores principales: | McCabe, Bronagh, Liberante, Fabio, Mills, Ken I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4488459/ https://www.ncbi.nlm.nih.gov/pubmed/26048243 http://dx.doi.org/10.1007/s00277-015-2412-1 |
Ejemplares similares
-
Selective serotonin reuptake inhibitor use and breast cancer survival: a population-based cohort study
por: Busby, John, et al.
Publicado: (2018) -
An integrated meta-analysis approach to identifying medications with potential to alter breast cancer risk through connectivity mapping
por: Thillaiyampalam, Gayathri, et al.
Publicado: (2017) -
The Potential Roles of Blood–Brain Barrier and Blood–Cerebrospinal Fluid Barrier in Maintaining Brain Manganese Homeostasis
por: McCabe, Shannon Morgan, et al.
Publicado: (2021) -
Drug repurposing in oncology: Compounds, pathways, phenotypes and computational approaches for colorectal cancer
por: Nowak-Sliwinska, Patrycja, et al.
Publicado: (2019) -
Repurposing Antipsychotics for Cancer Treatment
por: Vlachos, Nikolaos, et al.
Publicado: (2021)